Articles by Disease (Non Hodgkin's Lymphoma)

Choosing between Targeted Therapies for Rheumatoid Arthritis Patients: The Oncology Perspective

Journal: Current Rheumatology Reviews
Volume: 7
Page: 70-76
Author(s): Tim Bongartz

The Role of T-Helper Cells in Atherosclerosis

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 9
Page: 25-41
Author(s): X. Lu, D. Lu, U. Narayan and V. V. Kakkar

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Journal: Current Drug Delivery
Volume: 8
Page: 11-25
Author(s): Andrew V. Schally, Jorg B. Engel, Gunter Emons, Norman L. Block and Jacek Pinski

Radioimmunotherapy of Solid Tumors: Searching for the Right Target

Journal: Current Drug Delivery
Volume: 8
Page: 26-44
Author(s): Hong Song and George Sgouros

Emerging Role of ImmunoPET in Receptor Targeted Cancer Therapy

Journal: Current Drug Delivery
Volume: 8
Page: 70-78
Author(s): Jan Marik and Jagath R. Junutula

Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)

Journal: Current Cancer Drug Targets
Volume: 11
Page: 123-129
Author(s): R. Lai, G. Tonini, A. Falcone, J. Mackey, A. Russo, M. Caraglia, L. Chiusa, A. Giacobino, S. Rizzo, D. Santini, G. G. Baldi, V. Catalano, A. D. Manazza, E. Vasile, C. E. Cass, B. Vincenzi and G. Schiavon

Articles by Disease (Non Hodgkin's Lymphoma)

Choosing between Targeted Therapies for Rheumatoid Arthritis Patients: The Oncology Perspective

The Role of T-Helper Cells in Atherosclerosis

Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors

Radioimmunotherapy of Solid Tumors: Searching for the Right Target

Emerging Role of ImmunoPET in Receptor Targeted Cancer Therapy

Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)

The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis Inhibition

Delivery of Intracellular-Acting Biologics in Pro-Apoptotic Therapies

Bcl-2 Targeted-Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma

Novel Systemic Drugs for Cutaneous T-Cell Lymphoma